(Q35915868)

11 August 2017

1 reference

title

Gastric pacing is not enough: additional measures for an effective obesity treatment program (English)

1 reference

11 August 2017

0 references

Louis J Aronne

1

1 reference

11 August 2017

Jonathan A Waitman

series ordinal

2

1 reference

11 August 2017

publication date

1 September 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

14 Suppl 1

1 reference

11 August 2017

page(s)

S23-7

1 reference

https://scigraph.springernature.com/pub.10.1007/bf03342134

11 August 2017

exact match

0 references

cites work

Strategies and potential molecular targets for obesity treatment

1 reference

https://api.crossref.org/works/10.1007%2FBF03342134

The emerging science of body weight regulation and its impact on obesity treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03342134

Obesity, diabetes and the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03342134

Is the energy homeostasis system inherently biased toward weight gain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03342134

Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03342134

Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03342134

Should obese patients be counselled to follow a low-glycaemic index diet? Yes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03342134

A low-carbohydrate as compared with a low-fat diet in severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03342134

A randomized trial of a low-carbohydrate diet for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03342134

Sibutramine produces dose-related weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03342134

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03342134

Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers

21 January 2018

1 reference

12 December 2020

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

1 reference

12 December 2020

Weight management using a meal replacement strategy: meta and pooling analysis from six studies

1 reference

12 December 2020

Methods for voluntary weight loss and control. NIH Technology Assessment Conference Panel. Consensus Development Conference, 30 March to 1 April 1992

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03342134

1 reference

11 August 2017

1 reference